Cationic carbosilane dendrimers and oligonucleotide binding: an energetic affair
Source abstract
Abstract
Generation 2 cationic carbosilane dendrimers hold great promise as internalizing agents for gene therapy as they present low toxicity and retain and internalize the genetic material as an oligonucleotide or siRNA. In this work we carried out complete in silico structural and energetical characterization of the interactions of a set of G2 carbosilane dendrimers, showing different affinity towards two single strand oligonucleotide (ODN) sequences in vitro. Our simulations predict that these four dendrimers and the relevant ODN complexes are characterized by similar size and shape, and that the molecule-specific ODN binding ability can be rationalized only by considering a critical molecular design parameter: the normalized effective binding energy ΔG(bind,eff)/N(eff), i.e. the performance of each active individual dendrimer branch directly involved in a binding interaction.
Source: openalex_inverted_index · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Dendrimers and Hyperbranched Polymers · Advanced biosensing and bioanalysis techniques · RNA Interference and Gene Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Molecular Simulation Engineering (MOSE) Laboratory
DEA
University of Trieste
34127 Trieste, Italy
National Interuniversity Consortium for Material Science and Technology (INSTM)
References (55)
Show source-provided references
1. Ehterige · Nanomedicine · 2013 · 9 · 110.1016/j.nano.2012.05.013 ↗
2. Chow · Sci. Transl. Med. · 2013 · 5 · 216rv410.1126/scitranslmed.3005872 ↗
3. Lehner · Nanomedicine · 2013 · 9 · 74210.1016/j.nano.2013.01.012 ↗
4. Venditto · Adv. Drug Delivery Rev. · 2013 · 65 · 8010.1016/j.addr.2012.09.038 ↗
5. Duncan · Mol. Pharm. · 2011 · 8 · 201010.1021/mp200394t ↗
6. Kim · N. Engl. J. Med. · 2010 · 363 · 243410.1056/NEJMra0912273 ↗
7. Ferrari · Nat. Rev. Cancer · 2005 · 5 · 16110.1038/nrc1566 ↗
8. Jhaveri · Front. Pharmacol. · 2014 · 5 · 110.3389/fphar.2014.00077 ↗
9. Nicolas · Chem. Soc. Rev. · 2013 · 42 · 114710.1039/C2CS35265F ↗
10. Godin · Acc. Chem. Res. · 2011 · 44 · 97910.1021/ar200077p ↗
11. Moros · Curr. Med. Chem. · 2013 · 20 · 275910.2174/0929867311320220003 ↗
12. Sun · J. Controlled Release · 2012 · 164 · 15610.1016/j.jconrel.2012.05.042 ↗
13. Svenson · Mol. Pharm. · 2013 · 10 · 84810.1021/mp300644n ↗
14. Dawidczyk · J. Controlled Release · 2014 · 187C · 13310.1016/j.jconrel.2014.05.036 ↗
15. Wu · Sci. Transl. Med. · 2014 · 6 · 240ps710.1126/scitranslmed.3008362 ↗
16. Shen · Cancer Gene · 2012 · 19 · 36710.1038/cgt.2012.22 ↗
17. Viola · Expert Opin. Drug Deliv. · 2010 · 7 · 72110.1517/17425241003716810 ↗
18. Wu · Sci. World J. · 2013 · 63065410.1155/2013/630654 ↗
19. Shcharbin · Expert Opin. Drug Deliv. · 2013 · 10 · 168710.1517/17425247.2013.853661 ↗
20. Mintzer · Chem. Soc. Rev. · 2011 · 40 · 17310.1039/B901839P ↗
21. Maartens · Lancet · 2014 · 384 · 25810.1016/S0140-6736(14)60164-1 ↗
22. Deng · Gene · 2014 · 538 · 21710.1016/j.gene.2013.12.019 ↗
23. Date · Biomaterials · 2013 · 34 · 620210.1016/j.biomaterials.2013.05.012 ↗
24. Dassie · Ther. Delivery · 2013 · 4 · 152710.4155/tde.13.118 ↗
25. Zhou · BioDrugs · 2012 · 26 · 39310.1007/BF03261896 ↗
26. Dirin · Expert Opin. Biol. Ther. · 2013 · 13 · 87510.1517/14712598.2013.774366 ↗
27. Perisé-Barrios · J. Controlled Release · 2014 · 184 · 5110.1016/j.jconrel.2014.03.048 ↗
28. Pedziwiatr-Werbicka · Colloids Surf., B · 2013 · 109 · 18310.1016/j.colsurfb.2013.03.045 ↗
29. Pedziwiatr-Werbicka · J. Biomed. Nanotechnol. · 2012 · 8 · 5710.1166/jbn.2012.1369 ↗
30. Pedziwiatr · J. Fluoresc. · 2009 · 19 · 26710.1007/s10895-008-0412-4 ↗
31. Chonco · Org. Biomol. Chem. · 2007 · 5 · 188610.1039/B703989A ↗
32. Bermejo · Chem. – Eur. J. · 2007 · 13 · 48310.1002/chem.200600594 ↗
33. Ortega · Eur. J. Inorg. Chem. · 2006 · 138810.1002/ejic.200500782 ↗
34. Shcharbin · Biomacromolecules · 2007 · 8 · 205910.1021/bm070333p ↗
35. Pavan · Chem. – Eur. J. · 2010 · 16 · 778110.1002/chem.200903258 ↗
36. Wang · J. Comput. Chem. · 2004 · 25 · 115710.1002/jcc.20035 ↗
37. Schmidt · J. Comput. Chem. · 1993 · 14 · 134710.1002/jcc.540141112 ↗
38. M. S. Gordon and M. W.Schmidt, Advances in electronic structure theory: GAMESS a decade later, in Elsevier (Ed.) Theory and Applications of Computational Chemistry: the first forty years, Elsevier, Amsterdam, 2005, pp. 1167–1189
39. Lii · J. Comput. Chem. · 1991 · 12 · 18610.1002/jcc.540120208 ↗
40. Jorgensen · J. Chem. Phys. · 1983 · 79 · 92610.1063/1.445869 ↗
41. Ryckaert · J. Comput. Phys. · 1977 · 23 · 32710.1016/0021-9991(77)90098-5 ↗
42. Wu · Chem. Phys. Lett. · 2003 · 381 · 51210.1016/j.cplett.2003.10.013 ↗
43. Berendsen · J. Chem. Phys. · 1984 · 81 · 368410.1063/1.448118 ↗
44. Darden · J. Chem. Phys. · 1993 · 98 · 1008910.1063/1.464397 ↗
45. Laurini · Mol. Oncol. · 2013 · 7 · 96810.1016/j.molonc.2013.06.001 ↗
46. Park · J. Chem. Phys. · 2004 · 120 · 594610.1063/1.1651473 ↗
47. Park · J. Chem. Phys. · 2003 · 119 · 355910.1063/1.1590311 ↗
48. Isralewitz · J. Mol. Graphics Modell. · 2001 · 19 · 1310.1016/S1093-3263(00)00133-9 ↗
49. Srinivasan · J. Am. Chem. Soc. · 1998 · 120 · 940110.1021/ja981844+ ↗
50. Onufriev · J. Phys. Chem. B · 2000 · 104 · 371210.1021/jp994072s ↗
51. Feig · J. Comput. Chem. · 2004 · 25 · 26510.1002/jcc.10378 ↗
52. Maiti · Macromolecules · 2005 · 38 · 97910.1021/ma049168l ↗
53. Maiti · Macromolecules · 2004 · 37 · 623610.1021/ma035629b ↗
54. Rudnick · J. Phys. A: Math. Gen. · 1986 · 4 · L19110.1088/0305-4470/19/4/004 ↗
55. Tomalia · Angew. Chem., Int. Ed. Engl. · 1990 · 29 · 13810.1002/anie.199001381 ↗